- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cathepsin B: a potential prognostic marker for inflammatory breast cancer ; volume:9 ; number:1 ; day:3 ; month:1 ; year:2011 ; pages:1-8 ; date:12.2011
Journal of translational medicine ; 9, Heft 1 (3.1.2011), 1-8, 12.2011
- Creator
-
Nouh, Mohamed A.
- Contributor
-
Mohamed, Mona M.
El-Shinawi, Mohamed
Shaalan, Mohamed A.
Cavallo-Medved, Dora
Khaled, Hussein M.
Sloane, Bonnie F.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-9-1
- URN
-
urn:nbn:de:1111-2016041437858
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nouh, Mohamed A.
- Mohamed, Mona M.
- El-Shinawi, Mohamed
- Shaalan, Mohamed A.
- Cavallo-Medved, Dora
- Khaled, Hussein M.
- Sloane, Bonnie F.
- SpringerLink (Online service)
Other Objects (12)
Cathepsin S: therapeutic, diagnostic, and prognostic potential
Prognostic significance of serum inflammatory markers in esophageal cancer
Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
PCMT1 as a prognostic marker in breast cancer
Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion
Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Effects of six months of Yoga on inflammatory serum markers prognostic of recurrence risk in breast cancer survivors
Correction to: Prognostic significance of serum inflammatory markers in esophageal cancer
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
Cathepsin S: therapeutic, diagnostic, and prognostic potential
Prognostic significance of serum inflammatory markers in esophageal cancer
Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
PCMT1 as a prognostic marker in breast cancer
Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion
Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Effects of six months of Yoga on inflammatory serum markers prognostic of recurrence risk in breast cancer survivors
Correction to: Prognostic significance of serum inflammatory markers in esophageal cancer
Prognostic significance of tumour stroma ratio in inflammatory breast cancer
Cathepsin S: therapeutic, diagnostic, and prognostic potential
Prognostic significance of serum inflammatory markers in esophageal cancer
Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
PCMT1 as a prognostic marker in breast cancer
Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion
Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
Effects of six months of Yoga on inflammatory serum markers prognostic of recurrence risk in breast cancer survivors
Correction to: Prognostic significance of serum inflammatory markers in esophageal cancer